The global tumor ablation market reached a value of US$ 538.7 Million in 2018. Looking forward, the market is anticipated to reach a value of US$ 1,080 Million by 2024, registering a CAGR of around 12% during 2019-2024.
The increasing prevalence of cancer is one of the key factors driving the growth of the market. Furthermore, owing to benefits such as the lesser amount of trauma, speedy recovery, reduced complications and shorter hospital stay, MI procedures are gaining widespread preference, which, in turn, is driving the market growth.
Also, various technological advancements such as the introduction of thermal and laser ablation, irreversible electroporation and High-Intensity Focused Ultrasound (HIFU) have enhanced the acceptance of tumor ablation procedures. Moreover, the implementation of favorable government policies for cancer awareness and treatment methods is also creating a positive outlook for the market.
Other factors driving the market include growing healthcare expenditures and rising geriatric population, along with the increasing number of ablation and surgical centers and awareness for ablation procedures that can be conducted over small tumors.
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic, AngioDynamics Inc., HealthTronics Inc., NeuWave Medical, INTIO Inc., Galil Medical Ltd., Boston Scientific, Sonacare Medical, EDAP TMS S.A., ERBE Elektromedizin GmbH, IceCure Medical Ltd., MISONIX Inc., Endocare Inc., CooperSurgical Inc., B V M Meditech Pvt., etc.
Key Questions Answered in This Report
How has the global tumor ablation market performed so far and how will it perform in the coming years?
What are the key regional markets in the global tumor ablation industry?
What is the breakup of the market based on the technology?
What is the breakup of the market based on the mode of treatment?
What is the breakup of the market based on the mode of application?
What is the breakup of the market based on the end-user?
What are the various stages in the value chain of the global tumor ablation industry?
What are the key driving factors and challenges in the global tumor ablation industry?
What is the structure of the global tumor ablation industry and who are the key players?
What is the degree of competition in the global tumor ablation industry?
Key Topics Covered
2 Scope & Methodology
3 Executive Summary
4 Introduction 4.1 Overview 4.2 Key Industry Trends
5 Global Tumor Ablation Market 5.1 Market Overview 5.2 Market Performance 5.3 Market Breakup by Technology 5.4 Market Breakup by Treatment 5.5 Market Breakup by Application 5.6 Market Breakup by End-user 5.7 Market Breakup by Region 5.8 Market Forecast
10 Market Breakup by Mode of Treatment 10.1 Percutaneous Ablation 10.2 Laparoscopic Ablation 10.3 Surgical Ablation
11 Market Breakup by Application 11.1 Liver Cancer 11.2 Lung Cancer 11.3 Kidney Cancer 11.4 Bone Metastasis 11.5 Others
12 Market Breakup by End-User 12.1 Hospitals 12.2 Cancer Specialty Clinics 12.3 Others
13 Market Breakup by Region 13.1 North America 13.2 Europe 13.3 Asia Pacific 13.4 Middle East and Africa 13.5 Latin America
14 Competitive Landscape 14.1 Market Structure 14.2 Key Players 14.3 Profiles of Key Players 14.3.1 Medtronic 14.3.2 AngioDynamics Inc. 14.3.3 HealthTronics Inc. 14.3.4 NeuWave Medical 14.3.5 INTIO Inc. 14.3.6 Galil Medical Ltd. 14.3.7 Boston Scientific 14.3.8 Sonacare Medical 14.3.9 EDAP TMS S.A. 14.3.10 ERBE Elektromedizin GmbH 14.3.11 IceCure Medical Ltd. 14.3.12 MISONIX Inc. 14.3.13 Endocare Inc. 14.3.14 CooperSurgical Inc. 14.3.15 B V M Meditech Pvt.